MedTrace Logo

Carbon-Fibre Accessory (CARA) for Supine Breast Positioning to Reduce Toxicity in Whole Breast Radiotherapy

NCT04257396 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2023-01-25

No results posted yet for this study

Summary

This trial is designed to assess the efficacy of a novel carbon-fibre adjustable reusable accessory (CARA) for breast support to reduce skin toxicity and unwanted normal tissue dose in comparison to the current clinical standard for supine breast support during whole breast RT.

Conditions

  • Adjuvant Radiotherapy for Breast Cancer

Interventions

DEVICE

Carbon-Fibre Adjustable Reuseable Accessory (CARA)

Breast support device having a carbon-fibre breast cradle for supine patient positioning.

Sponsors & Collaborators

  • Canadian Cancer Society (CCS)

    collaborator OTHER

  • British Columbia Cancer Agency

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-11
Primary Completion
2024-07-31
Completion
2024-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04257396 on ClinicalTrials.gov